Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand?

被引：8
|
作者：
Dapra, Valentina [1 ,2 ]
Airoldi, Marco [1 ,2 ]
Bartolini, Michela [1 ,2 ]
Fazio, Roberta [1 ,2 ]
Mondello, Giuseppe [2 ]
Tronconi, Maria Chiara [2 ]
Prete, Maria Giuseppina [2 ]
D'Agostino, Giuseppe [3 ]
Foppa, Caterina [1 ,4 ]
Spinelli, Antonino [1 ,4 ]
Puccini, Alberto [2 ]
Santoro, Armando [1 ,2 ]
机构：
[1] Humanitas Univ, Dept Biomed Sci, I-20072 Pieve Emanuele, Italy
[2] IRCCS Humanitas Res Hosp, Humanitas Canc Ctr, Med Oncol & Hematol Unit, I-20089 Rozzano, Italy
[3] IRCCS Humanitas Res Hosp, Radiotherapy & Radiosurg Dept, I-20089 Rozzano, Italy
[4] IRCCS Humanitas Res Hosp, Div Colon & Rectal Surg, I-20089 Rozzano, Italy
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 15期
关键词：
locally advanced rectal cancer; total neoadjuvant therapy; rectal cancer; nonoperative management; ct-DNA; MMR-deficient tumor; TOTAL MESORECTAL EXCISION; SHORT-COURSE RADIOTHERAPY; METASTATIC COLORECTAL-CANCER; PHASE-III TRIAL; PREOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; OPEN-LABEL; POSTOPERATIVE CHEMORADIOTHERAPY; FOLLOW-UP;
D O I：
10.3390/ijms241512159
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The therapeutic landscape in locally advanced rectal cancer (LARC) has undergone a significant paradigm shift in recent years with the rising adoption of total neoadjuvant treatment (TNT). This comprehensive approach entails administering chemotherapy and radiation therapy before surgery, followed by optional adjuvant chemotherapy. To establish and deliver the optimal tailored treatment regimen to the patient, it is crucial to foster collaboration among a multidisciplinary team comprising healthcare professionals from various specialties, including medical oncology, radiation oncology, surgical oncology, radiology, and pathology. This review aims to provide insights into the current state of TNT for LARC and new emerging strategies to identify potential directions for future research and clinical practice, such as circulating tumor-DNA, immunotherapy in mismatch-repair-deficient tumors, and nonoperative management.
引用
收藏
页数：16
相关论文
共 50 条
  • [41] Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer
    Zhang, Jianwei
    Huang, Meijin
    Cai, Yue
    Wang, Lei
    Xiao, Jian
    Lan, Ping
    Hu, Huabin
    Wu, Xiaojian
    Ling, Jiayu
    Peng, Junsheng
    Chen, Dianke
    Kang, Liang
    Zhang, Yan
    Ren, Donglin
    Wang, Hui
    Chen, Shuang
    Lin, Feng
    Zheng, Jian
    Zhou, Zhiyang
    Wang, Jianping
    Deng, Yanhong
    CLINICAL COLORECTAL CANCER, 2019, 18 (04) : 238 - 244
  • [42] Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: A phase 2 trial
    Wang, Xin
    Yu, Yongyang
    Meng, Wenjian
    Jiang, Dan
    Deng, Xiangbing
    Wu, Bing
    Zhuang, Hua
    Wang, Cun
    Shen, Yali
    Yang, Lie
    Zhu, Hong
    Cheng, Ke
    Zhao, Yaqin
    Li, Zhiping
    Qiu, Memg
    Gou, Hongfeng
    Bi, Feng
    Xu, Feng
    Zhong, Rrenmin
    Bai, Sen
    Wang, Ziqiang
    Zhou, Zongguang
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 300 - 305
  • [43] Efficacy and safety of different radiotherapy doses in neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: A retrospective study
    Xu, Yuyan
    Zou, Haizhou
    Shao, Zhenyong
    Zhang, Xuebang
    Ren, XiaoLin
    He, Huijuan
    Zhang, Dahai
    Du, Dexi
    Zou, Changlin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Locally advanced rectal cancer: The past, present, and future
    Oronsky, Bryan
    Reid, Tony
    Larson, Chris
    Knox, Susan J.
    SEMINARS IN ONCOLOGY, 2020, 47 (01) : 85 - 92
  • [45] Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer
    Sun, Z.
    Adam, M. A.
    Kim, J.
    Turner, M. C.
    Fisher, D. A.
    Choudhury, K. R.
    Czito, B. G.
    Migaly, J.
    Mantyh, C. R.
    COLORECTAL DISEASE, 2017, 19 (12) : 1058 - 1066
  • [46] Total neoadjuvant therapy for locally advanced rectal cancer: a three-group propensity score matched study
    Zhou, Jiahao
    Huang, Jun
    Zhou, Zikai
    Deng, Xiangbing
    Wu, Qingbin
    Wang, Ziqiang
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2024, 39 (01)
  • [47] Role of radiation therapy in neoadjuvant era in patients with locally advanced rectal cancer
    Koukourakis, Georgios V.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2012, 4 (12) : 230 - 237
  • [48] Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
    Papaccio, Federica
    Rosello, Susana
    Huerta, Marisol
    Gambardella, Valentina
    Tarazona, Noelia
    Fleitas, Tania
    Roda, Desamparados
    Cervantes, Andres
    CANCERS, 2020, 12 (12) : 1 - 12
  • [49] Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy
    Yoo, Ri Na
    Kim, Hyung Jin
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2019, 3 (04): : 356 - 367
  • [50] Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival
    Zhang, Haoyu
    Li, Ganbin
    Cao, Ke
    Zhai, Zhiwei
    Wei, Guanghui
    Qu, Hao
    Wang, Zhenjun
    Han, Jiagang
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (07) : 1657 - 1668
12345